PATENT CLAIM ANALYSIS

Application Number: 16279819
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-09
Patent Classification: ["514", "560000"]

Abstract:
The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Claim (Index 29):
The method of  claim 28 , wherein the fasting conditions further comprise no food prior to administration of the effective dose of DGLA and no liquids, besides water, prior to administration of the effective dose of DGLA.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.13636
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15661374', '14730818', '15667683', '16198645', '14882662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7332942892844618
- 35 USC 102 Novelty (BERT): 0.5663801461247904
- Combined Prediction Score: 0.7166028749684947
- Mean Citation Score: 274.135856
- Max Citation Score: 409.79233
- Similarity Product: 251.44078835438071

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test